SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by LPL Financial LLC

LPL Financial LLC reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 620,671 shares of the exchange traded fund’s stock after selling 21,113 shares during the period. LPL Financial LLC owned about 0.98% of SPDR S&P Biotech ETF worth $50,336,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in XBI. Bearing Point Capital LLC increased its stake in SPDR S&P Biotech ETF by 1.9% during the first quarter. Bearing Point Capital LLC now owns 59,155 shares of the exchange traded fund’s stock valued at $4,797,000 after purchasing an additional 1,131 shares during the last quarter. Nvwm LLC increased its stake in SPDR S&P Biotech ETF by 11.4% during the first quarter. Nvwm LLC now owns 13,173 shares of the exchange traded fund’s stock valued at $1,068,000 after purchasing an additional 1,344 shares during the last quarter. First Heartland Consultants Inc. increased its stake in SPDR S&P Biotech ETF by 2.7% during the first quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock valued at $514,000 after purchasing an additional 168 shares during the last quarter. Cetera Investment Advisers increased its stake in SPDR S&P Biotech ETF by 3.8% during the first quarter. Cetera Investment Advisers now owns 154,330 shares of the exchange traded fund’s stock valued at $12,516,000 after purchasing an additional 5,604 shares during the last quarter. Finally, Garrison Bradford & Associates Inc. bought a new stake in SPDR S&P Biotech ETF during the first quarter valued at $39,000.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $85.66 on Friday. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $105.47. The firm has a fifty day moving average price of $84.19 and a two-hundred day moving average price of $84.26. The firm has a market cap of $4.64 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.